AMANDA ESTUPINAN: Open Payments
NPI 1801491477 · BARTOW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 10 payments from 6 companies in 2025. Trend: 2023 $447 · 2024 $343 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| Lilly USA, LLC | 1 | $58 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Optinose US, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: DUPIXENT, ZEPBOUND, VOQUEZNA, Xhance, NUCALA.
Industry payments across FL — which companies pay providers there.
